Allspring Global Investments Holdings LLC cut its position in Dun & Bradstreet Holdings, Inc. (NYSE:DNB - Free Report) by 15.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,799,036 shares of the business services provider's stock after selling 3,279,078 shares during the quarter. Allspring Global Investments Holdings LLC owned about 3.99% of Dun & Bradstreet worth $159,479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also bought and sold shares of the company. Amundi lifted its stake in Dun & Bradstreet by 27.9% in the 4th quarter. Amundi now owns 5,158 shares of the business services provider's stock worth $64,000 after purchasing an additional 1,126 shares in the last quarter. Cetera Investment Advisers lifted its stake in Dun & Bradstreet by 5.5% in the 4th quarter. Cetera Investment Advisers now owns 23,843 shares of the business services provider's stock worth $297,000 after purchasing an additional 1,240 shares in the last quarter. Xponance Inc. lifted its stake in Dun & Bradstreet by 16.5% in the 4th quarter. Xponance Inc. now owns 13,252 shares of the business services provider's stock worth $165,000 after purchasing an additional 1,881 shares in the last quarter. Cerity Partners LLC lifted its stake in Dun & Bradstreet by 10.1% in the 4th quarter. Cerity Partners LLC now owns 20,771 shares of the business services provider's stock worth $259,000 after purchasing an additional 1,909 shares in the last quarter. Finally, Truist Financial Corp raised its position in shares of Dun & Bradstreet by 8.7% during the 4th quarter. Truist Financial Corp now owns 24,420 shares of the business services provider's stock valued at $304,000 after buying an additional 1,958 shares in the last quarter. 86.68% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Dun & Bradstreet
In other Dun & Bradstreet news, Director Chinh Chu sold 10,885,403 shares of the firm's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $8.95, for a total value of $97,424,356.85. Following the sale, the director now owns 23,810 shares of the company's stock, valued at $213,099.50. This trade represents a 99.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman William P. Foley II sold 2,500,000 shares of the firm's stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $8.96, for a total transaction of $22,400,000.00. Following the completion of the sale, the chairman now directly owns 5,609,644 shares in the company, valued at approximately $50,262,410.24. This trade represents a 30.83% decrease in their position. The disclosure for this sale can be found here. 10.44% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on DNB shares. Raymond James Financial cut shares of Dun & Bradstreet from a "strong-buy" rating to a "market perform" rating in a research report on Friday, June 13th. Wall Street Zen started coverage on shares of Dun & Bradstreet in a research report on Wednesday, May 21st. They set a "hold" rating on the stock. Needham & Company LLC restated a "hold" rating on shares of Dun & Bradstreet in a research report on Friday, May 2nd. Finally, Jefferies Financial Group restated a "hold" rating and set a $9.15 price objective (down previously from $11.00) on shares of Dun & Bradstreet in a research report on Tuesday, March 25th. Eight equities research analysts have rated the stock with a hold rating, According to data from MarketBeat, Dun & Bradstreet currently has a consensus rating of "Hold" and an average target price of $11.86.
Check Out Our Latest Report on DNB
Dun & Bradstreet Trading Up 0.1%
Shares of DNB stock traded up $0.01 on Friday, hitting $9.09. 2,541,630 shares of the company's stock traded hands, compared to its average volume of 6,312,525. The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.62 and a current ratio of 0.62. Dun & Bradstreet Holdings, Inc. has a one year low of $7.78 and a one year high of $12.95. The company's fifty day simple moving average is $9.01 and its 200 day simple moving average is $9.87. The stock has a market capitalization of $4.06 billion, a price-to-earnings ratio of -181.70 and a beta of 1.12.
Dun & Bradstreet (NYSE:DNB - Get Free Report) last released its earnings results on Thursday, May 1st. The business services provider reported $0.21 EPS for the quarter, beating the consensus estimate of $0.20 by $0.01. Dun & Bradstreet had a negative net margin of 0.88% and a positive return on equity of 11.51%. The company had revenue of $579.80 million for the quarter, compared to analyst estimates of $578.02 million. During the same quarter last year, the firm earned $0.20 EPS. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. Equities analysts forecast that Dun & Bradstreet Holdings, Inc. will post 0.96 EPS for the current year.
About Dun & Bradstreet
(
Free Report)
Dun & Bradstreet Holdings, Inc engages in providing business decisioning data and analytics solutions. The firm is involved in providing information with its solutions to support its clients with critical business operations. It offers end-to-end solutions to clients in the small business, finance, sales & marketing, third party risk & compliance, and public sectors.
See Also

Before you consider Dun & Bradstreet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dun & Bradstreet wasn't on the list.
While Dun & Bradstreet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.